The Southern Medical Journal (SMJ) is the official, peer-reviewed journal of the Southern Medical Association. It has a multidisciplinary and inter-professional focus that covers a broad range of topics relevant to physicians and other healthcare specialists.

SMJ // Article

Original Article

Perspectives on Contraceptive Research for Individuals with Increased Thrombosis Risk: A Qualitative Exploration of Patients and Clinicians

Authors: Mingma L. Sherpa, MD, MS, Ella J. Siegrist, MA, Larissa Myaskovsky, PhD, Andrew L. Sussman, PhD, MCRP, Karen C. Chong, MD, Victoria Y. Trujillo, BA, Jamie W. Krashin, MD, MSCR

Abstract

Objectives: Although most progestin-only contraceptives are generally considered safe for most patients at increased risk of arterial and venous thrombosis, patients and clinicians may be wary of their use based on limited studies. Large prospective contraceptive studies with primary data collection would improve the evidence base for people at increased thrombosis risk. We therefore aimed to find solutions for recruitment and long-term retention of representative participants in large prospective studies of contraceptives for patients at increased risk of thrombosis, identify patient- and clinician-prioritized outcomes, and determine patients' and clinicians' preferred dissemination methods for study results.

Methods: In this formative qualitative study, we conducted semistructured interviews with reproductive-age patients at increased thrombosis risk and clinicians in related fields in New Mexico via telephone and Zoom. Interviews were transcribed and coded deductively using Dedoose qualitative coding software. We categorized emerging themes based on our study aims.

Results: We interviewed 16 patients and 11 clinicians from June 2020 to June 2022. Most of the patients (60%) had more than one of the following conditions: hypertension, antiphospholipid antibody syndrome, history of cerebral vascular accident, deep vein thrombosis, pulmonary embolism or myocardial infarction, systemic lupus erythematosus, or a thrombophilia. Clinician specialties included hematology, rheumatology, pulmonology, pharmacy, and women's health. The majority of respondents participated to help others. Although participants highlighted discomfort with reproductive health as a potential barrier to participation, others indicated that they wanted to share their difficult experiences to bring awareness to the topic. Virtual participation in interviews overcame several participation barriers such as scheduling concerns, transportation, and finding childcare. Patients and clinicians both cited effectiveness, safety, side effects, and developing more contraceptive method options as priority research outcomes. All of the participants were interested in receiving the results of the study in which they participated. Clinicians recommended constructing research teams reflecting participant demographics.

Conclusions: Altruism may be a strong motivator for contraceptive research participation among medically complex patients. Both patients and clinicians desire new efficacious, safe, low side effect contraceptives for patients at increased thrombosis risk. Virtual participation options address common participant recruitment and, likely, retention barriers. Clinicians anticipate that research teams that reflect participant demographics may lead to better representation of at-risk populations in contraceptive research.
Posted in: Family Planning & Reproductive Health17

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. Medical Eligibility Criteria for contraceptive use, 2016. MMWR Recomm Rep 2016;65:1-103.
 
2. Lidegaard Ø, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012;366:2257-2266.
 
3. O’Brien SH, Koch T, Vesely SK, et al. Hormonal contraception and risk of thromboembolism in women with diabetes. Diabetes Care 2017;40:233-238.
 
4. Dinger J, Shapiro S. Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets. J Fam Plann Reprod Health Care 2012;38:2-6.
 
5. Dinger J, Bardenheuer K, Heinemann K. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives. Contraception 2014;89:253-263.
 
6. Tepper NK, Curtis KM, Nguyen AT, et al. Research gaps in evidence-based contraception guidance: US Medical Eligibility Criteria for Contraceptive Use, 2024, and US Selected Practice Recommendations for Contraceptive Use, 2024. Contraception 2025;111209.
 
7. National Academies of Sciences, Engineering, and Medicine Policy and Global Affairs Committee on Women in Science, Engineering, and Medicine Committee on Improving the Representation of Women and Underrepresented Minorities in Clinical Trials and Research. Improving representation in clinical trials and research: building research equity for women and underrepresented groups. In: Domingo K, Helman A, eds. Washington (DC): National Academies Press (US) 2022.
 
8. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009;42:377-381.
 
9. Guest G, Bunce A, Johnson L. How many interviews are enough?: An experiment with data saturation and variability. Field Methods 2006;18:59-82.
 
10. Carrera JS, Brown P, Brody JG, et al. Research altruism as motivation for participation in community-centered environmental health research. Soc Sci Med 2018;196:175-181.
 
11. Rosenbaum JR, Wells CK, Viscoli CM, et al. Altruism as a reason for participation in clinical trials was independently associated with adherence. J Clin Epidemiol 2005;58:1109-1114.
 
12. Lerma K, Arey W, Chatillon A, et al. Reasons for participation in abortion research in restrictive settings. Contraception 2024;130:110324.
 
13. Boland J, Banks S, Krabbe R, et al. A COVID-19-era rapid review: using Zoom and Skype for qualitative group research. Public Health Res Pract 2022;32:31232112.
 
14. Akyirem S, Ekpor E, Aidoo-Frimpong GA, et al. Online interviews for qualitative health research in Africa: a scoping review. Int Health 2024;16:4-13.
 
15. Cashman SB, Adeky S, Allen AJ, et al. The Power and the promise: working with communities to analyze data, interpret findings, and get to outcomes. Am J Public Health 2008;98:1407-1417.
 
16. Speidel JJ, Townsend J, Williams E, et al. Commentary on research to improve contraceptive and multipurpose prevention technologies. Contraception 2020;101:148-152.
 
17. Kidula N, Nguyen BT, Habib N, et al. The impact of male contraception on global sexual and reproductive health and rights. Contraception 2025;145:110811.
 
18. US Food and Drug Administration. FDA approves first nonprescription daily oral contraceptive 2023. https://www.fda.gov/news-events/press-announcements/fda-approves-first-nonprescription-daily-oral-contraceptive. Accessed October 20, 2023.